nivolumab,ipilimumab
bms
[]
#esmo22 patient disposition here - of 26 patients who completed induction therapy, 3 are still on therapy and 24 completed surgery. included 66% t4 and 59% n0 (only 13% n2). majority (63%) had pdl1 high disease. there was one g5 ae (covid). no ae prevented surgery. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him